Skip to main content
  1. Right Decisions
  2. GGC - Clinical Guidelines
  3. Gynaecology
  4. Gynaecology guidelines
  5. Back
  6. Guidelines A-Z (all Gynaecology guidelines)
  7. Management of Endometrial Hyperplasia (124)

Management of Endometrial Hyperplasia (124)

Please report any inaccuracies or issues with this guideline using our online form

Endometrial cancer is the most common gynaecological malignancy in the Western world and endometrial hyperplasia is its precursor. The most common presentation of endometrial hyperplasia is abnormal uterine bleeding (this includes HMB, IMB, PMB and bleeding on HRT)

Resources

Use the button below to access this item.

Access this resource

Editorial Information

Last reviewed: 24/06/2026

Next review date: 24/06/2031

Author(s): Claire Higgins.

Version: 4

Approved By: Gynaecology Clinical Governance Group

Document Id: 124